A 39-year-old woman with biochemically and clinically active acute intermittent porphyria (AIP) developed moderately severe liver injury after receiving her second dose of givosiran. Serologic evaluation ruled out hepatitis caused by viral, autoimmune, or other metabolic etiologies. The updated Roussel Uclaf Causality Assessment Method (RUCAM) score was 8 and the Revised Electronic Causality Assessment Method (RECAM) score for givosiran was 9. Results of liver tests returned to normal after givosiran was discontinued, and she has not received any more givosiran.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9791166 | PMC |
| http://dx.doi.org/10.1016/j.ymgmr.2022.100946 | DOI Listing |
Publication Analysis
Top Keywords
liver injury
8
acute intermittent
8
intermittent porphyria
8
causality assessment
8
assessment method
8
givosiran
5
idiosyncratic drug-induced
4
drug-induced liver
4
injury caused
4
caused givosiran
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!